You just read:

Allergan Announces Settlement on RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% Patent Litigation with InnoPharma, Inc.

News provided by

Allergan plc

Oct 12, 2017, 16:15 ET